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ABSTRACT  
 
Gloriosa superba L. is an important medicinal plant of Asia and Africa. It is used in diseases, like cancer, gout, scrofula and 
act as antipyretic, antihelmintic, purgative and antiabortive. It is a source of colchicines and colchicocides, which are very 
costly, being highly demanded by pharma industries. Due to excessive use of the plant for diverse medicinal purposes the 
species is on the verge of extinction and included in Red Data Book. The strenuous efforts of botanists, biotechnologists, 
policy makers and conservationists are required. It is a matter of great concern to conserve this plant otherwise we will be 
loosing it by 2020.The present review is focused on current status of the genus, source of alkaloids, poisonous nature, the 
strategies for its conservation and future perspectives of G. superba. 
© 2009 Biodiversitas, Journal of Biological Diversity 
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INTRODUCTION 
From the beginning of human civilization the plants 
and their products particularly ethnomedicinal plants 
plays a great role. The antique traditional medicines 
and prescriptions at a halt exist and largely practiced. 
The ethnobotanists are trying to ascertain new 
medicines from the forests by the help of tribal 
people. In India, the population of tribal people is 
around fifty three million along with 555 tribal groups 
or communities, which are reside in forest and 
srounding. These people have enormous indigenous 
knowledge which is a possible tool to explore for 
novel cost-effective plants for food as well as 
medicine. Several medicinal plants were originally 
identified and developed through indigenous 
knowledge, thus ethnomedicines have played key 
role in the development of drugs used in modern 
system of medicine. The plant drugs which are 
originated and developed are cocaine, morphine, 
quinine, colchicine, atropine, ephedrine, codeine, 
emetine, caffeine, resurpine, vinablastin, vincristin, 
and guguline etc. The medicinal plants play a major 
role in remedial now a days. The entire planet is in 
search of renovating herbal medicinal plants and its 
application for the betterment of mankind. World 
Health Organization (WHO) has previously 
recognized to re-establish the traditional knowledge of 
medicine among our conventional theaters. 
Traditional knowledge since 200 B.C. in Ayurveda is 
very well recognized especially in India among tribal 
people. 
Gloriosa superba L. (Colchicaceae) also known as 
Malabar glory lily or “kembang telang” (Java, 
Indonesia) is a perennial tuberous climbing herb, 
extensively scattered in the tropical and sub-tropical 
parts of the India, including the foothills of Himalayas. 
It is called as ‘Mauve beauty’, ‘Purple prince’, 
‘Modest’, ‘Orange gem’, ‘Salman glow’ and ‘Orange 
glow’ (Bose and Yadav, 1989). It is adapted to 
different soil texture and climatic variation. The plant 
grows in sandy-loam soil in the mixed deciduous 
forest in sunny positions. It is very tolerant of nutrient-
poor soils. It occurs in thickets, forest edges and 
boundaries of cultivated areas in warm countries upto 
height of 2530 m. (Neuwinger, 1994). G. superba is a 
inhabitant of tropical Africa and now found growing 
naturally in many countries of tropical Asia including 
Bangladesh, India, Sri Lanka, Malaysia and 
Myanmar. In India, it occurs commonly in tropical 
forests of Bengal and Karnataka (Sivakumar and 
Krishnamurthy, 2002). The plant thrive from   
Bundelkhand to humid Assam valley. It is known by 
different names in India such as ‘Kalihari’, 
‘Agnishikha’, ‘Languliata’, and ‘Nangulika’. There are 
several associated species of Gloriosa including G. 
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planti, G. lipolidii, G. longifolia, G. rotheschildiana, G. 
virenses,  G. sudanica, etc. These species are 
distributed mainly in Africa. Besides many hybrids 
popular garden cultivars like the purple prince, African 
chief, orange gem, orange gift, lavender lady, and 
orange ball are grown for ample range of flowers and 
colour combination of the perienth, which bloom for 
long during the autumn. G. superba is also known as 
the national flower of Zimbabwe. Except diverse 
pharmaceutical products and other therapeutic 
preparations, it is also a popular plant for providing 
colour in greenhouse and conservatories even 
immature flowers are gorgeous to behold (Kranse, 
1986; Ghani, 2000). G. superba is a semi-woody 
herbaceous branched climber, reaching just about 
five meters in height. One to four stems arise from a 
single V-shaped fleshy cylindrical tuber. Gloriosa 
superba is an imperative medicinal plant, all parts are 
used in the medicine, which contains two important 
alkaloid, colchicine and colchicoside, leaves are used 
to treat cancer related diseases, also in ulcer, piles, 
and scrofula (Evans et al., 1981).  
THE CURRENT STATUS  
The leaf juice of Gloriosa is used to kill-lice in hair, 
tubers contain the bitter principles, superbine and 
gloriosine, which in large doses are fatal; however, in 
small doses they are used as tonic, antiabortive, and 
purgatives. The white flour prepared from the tubers 
is bitter and used as  stimulant. It is given with honey 
in gonorrhea, leprosy, colic and intestinal worms and 
for promoting labor pains, a paste of tubers is applied 
over the suprapubic region and vagina. Its warm-
poultice is locally applied in rheumatism and neuralgic 
pains (Samy et al., 2008). Medicinally, the tuber is 
used as abortifacient, and in small dose it acts as a 
tonic, stomachic and anthelmintic. It is also used in 
the treatment of gout because it contains colchicine. 
Paste of the tuber is externally applied for parasitic 
skin diseases.  
Samy et al. (2008)  conducted ethnobotanical 
survey of folk plants for the treatment of snakebites in 
southern part of Tamilnadu, India, in which traditional 
approach was evaluated methodically with some 
selected plant extracts which showed potent 
neutralizing effect against the venom. The 
conventional method of propagation is through corms, 
since poor seed germination restrict their use in 
multiplication. Therefore, propagation by tissue 
culture technique is necessary (Finnie and van 
Staden, 1989, 1991). G. superba contains about 0.1-
0.8% colchicine in bulb which is used in plant 
breeding to induce mutation and polyploidy and also 
can solve an important problem in fuchsia breeding. 
G. superba also produces another alkaloid gloriosine. 
Colchicines affect cell membrane structure indirectly 
by inhibiting the synthesis of membrane constituent. It 
binds to tubelin preventing its polymerization into 
microtubules. This anti-mitotic property disrupts the 
spindle apparatus that separate chromosomes 
throughout metaphase, cells with high metabolic rates 
are most implicated by the arrest of mitosis. Kumar 
(1953) studied doubling of chromosomes induced by 
gloriosine isolated from G. superba.  
Jitpakdi et al. (1999) screened ten plant species 
including  G. superba for metaphase chromosome 
preparation in adult mosquitoes (Diptera: Culicidae) 
using an inoculation technique for colchicine like 
substances using a mosquito cytogenetic assay have 
shown the increased metaphase chromosome. Due 
to overexploitation for its diverse medicinal 
applications  G. supreba has been endangered, 
therefore, there is urgent need to conserve the plant 
by biotechnological approaches like tissue culture. 
(Rajgopalan and Khader, 1994). This approach has 
been very important because it provides complete 
sterile and virus-free plants by rapid multiplication. G. 
superba is now promising as an industrial medicinal 
crop in Asia particularly in South India for its high 
colchicine content. For commercial production of 
colchicine and its derivatives, natural production from 
in vitro methods of the source plant are thus of great 
attention. In the past two decades, focus has been on 
plant biotechnology as a potential alternative 
production method, using cultured cells rather than 
plants.  
SOURCE OF PRECIOUS ALKALOIDS 
G. superba produces two important alkaloid 
colchicine and gloriosine, which are present in seeds 
and tubers while the other compounds such as lumi-
colchicine, 3-demethyl-N-deformyl-N-deacetylcolchicine, 
3-demethylcolchicine, N-formyl deacetylcolchcine 
have been isolated from the plant (Sugandhi, 2000; 
Suri, 2001). Suri et al. (2001) reported new colchicine 
glycoside, 3-O-demethylcolchicine-3-O-alpha-D-
glucopyranoside in G. superba seeds. Kaur et al. 
(2007) studied purification of 3-monomeric monocot 
mannose-binding lectins and their evaluation for 
antipoxviral activity isolated from G. superba. 
Alkaloids are structurally heterogeneous class of 
secondary biomolecules derived from basically five 
amino acids ornithine, lysine, phenylalanine, tyrosine 
and tryptophan (Thakur, 1975). Thakur et al. (1975) 
reported the substances from plant of the sub-family 
Wurmbaeoideae and their derivatives along with 
alkaloids from the G. superba.  
COLCHICINE   
It is conventional drug for gout obtained from 
corms of G. superba and Colchicum autumnale 
(Thakur, 1975; Sivakumar and Krishnamurthy, 2002). 
The term “colchicine” is derived from area known as 
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Europe and Africa. Thomson was the first who 
proposed early idea of action of colchicines in gout 
treatment. Gout and uric acid metabolism is same 
way linked and colchicines might act on this and it is 
casued by deposition of microcrystals of uric acid in 
joints and may be due to defective regulatory 
mechanism for endogenous purine synthesis but 
contradictory result for the action of colchicine on 
synthesis and extraction of urates have been 
recorded, colchicines interrupt, the cycle of new 
deposition which seem to be indispensable for the 
persistence of acute gout. Distressing side effect has  
also been recorded sporadically but colchicines 
remain the drug for acute gout. Modification of the 
side chain of rings do not abolish anti-gout activity as 
long as the configuration of C-ring confirms to that of 
colchicines. It also acts as anti-mitotic and anti-gout 
agent. It blocks or suppresses cell division by 
inhibiting mitosis. It inhibits the development of 
spindles as the nuclei are dividing (spindles are 
formed by the polymerization of tubuline) from a pool 
of subunit during a detached phase of cell-cycle and 
then depolymerized during other phase. It is also 
used to induce polyploidy initiation, occasionally other 
mutations also occur like chlorophyll mutations, but 
frequency is low. 
It can solve an important problem of fuchsia 
breeding. Most of the fuchsia species are diploid or 
tetraploid, a crossing between diploid and tetraploid 
result often in a triploid, which is mostly sterile 
because the process of meiosis (cell division for 
reproduction) requires the coupling of similar 
chromosomes and there is no mechanism allowing for 
the alignment of three similar chromosomes, triploid 
plants are not able to produce fertile reproductive 
cells. They are, therefore, sterile and unusable as 
parents. A special problem of colchicines induced 
ploidy, particularly in vegetatively propagated crops, 
is the chimerism caused by the instantaneous 
presence of tissue of different ploidy levels in one 
plant or plant parts. Colchicine is mostly used in its 
freshly prepared aqueous form. The range of 
concentration of colchicine applied varies from 0.006-
3%, concentration of about 0.05% is the most 
commonly used (Milne and Meek, 1998). Kanan et al. 
(2007) studied optimization of solvents for efficient 
isolation of colchicines from G. superba. The 
maximum yield of colchicine was obtained when it is 
extracted with water and alcohol in the ratio of 50:50.  
 Bellet and Gaignault (1985) reported the 
production of colchicinic substance from G. superba. 
The colchicines-like activity of G. superba-extracted 
for mosquito (Diptera: Culicide) in which four fractions 
i.e. hexane fractions, dichloromethane fraction-1, 
dichloromethane fraction-2 and methanol fraction 
were investigated. The latter three fractions yielded 
hopefully high colchicine like activity, whereas hexane 
fraction yielded very low activity. 
Ghosh et al. (2002) studied the root culture of G. 
superba by using direct and indirect precursor of the 
biosynthetic pathway for the enhancement of 
colchicine production. They successfully used 
aluminium chloride as an elicitor, in which they have 
used root cultures of G. superba treated with 5 mM 
methyl jasmonate and 125 µM AlCl3. The enhancement 
of intracellular colchicine content was  observed in the 
roots by 50-fold and 63-fold respectively. Ghosh et al. 
(2006) reported that colchicine can also be applied in 
the lanolin paste or as a solution, for instance, on a 
cotton dot, placed in a leaf axil. Khan et al. (2007) 
evaluated the enzyme inhibition activities of G. 
superba  rhizomes extract against lipoxygenase, 
actylcholinesterase, butyrycholinesterase and urease 
in which wonderful inhibition was observed on 
lipoxygenease. Further, Khan et al. (2008) reported 
antimicrobial potential of G. superba extracts in which 
excellent antifungal activity was confirmed against 
Candida albicans,  C. glabrata,  Trichophyton 
longifusus,  Microsporum canis and Staphylococcus 
aureus. 
Colchicine is synthesized using mainly aromatic 
amino acids such as tryptophan, phenylalanine and 
tyrosine. Key enzymes involved in colchicine 
metabolism are tyrosine ammonia lyase (TAL) and 
phenylalanine ammonia lyase (PAL). Sivakumar and 
Krishnamurthy (2004)  reported the biosynthesis of 
colchicine, the in vitro supply of exogenous precursor 
using B5 medium from G. superba calluses. The 
maximum amount of colchicine i.e. 9.0 mg was 
detected in the medium fed with 30 μM tyrosine. The 
activity of TAL was higher than that of PAL and a low 
frequency of tracheary elements was observed. 
POISONING NATURE OF PLANT 
The colchicine which is a major component of 
Gloriosa is mainly responsible for toxic effect 
(Vishwanathan and Joshi, 1983). The toxins present 
have an inhibitory action on cell division, and 
depressant action on the bone marrow. Just after 
ingestion of tubers, the symptom develops within two 
hours; vomiting, numbness and severe effects on 
throat as well as diarrhea leading to dehydration. 
Alopecia and dermatitis are the major symptoms 
develop after two to three weeks after poisoning 
(Jayaweera, 1982). Colchicine poisoning following 
ingestion of G. superba tubers have been reported by 
various investigators (Nagratnam et al., 1973; Jose 
and Ravindran, 1988; Fernando and Fernando, 
1990). Mendis (1989) reported the toxicity symptoms 
as gastroenteritis, acute renal failure, cordiotoxicity 
and hematological abnormalities. Moreover, there 
were eight deaths due to G. superba, while the 
gastrointestinal symptoms along with sweating, 
hypotension jaundice and convulsions were reported 
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CONSERVATION BY MEANS OF IN VITRO 
PROPAGATION 
Gloriosa superba usually multiply by corm and 
seeds but due to low germination capability it restricts 
for the regeneration. Therefore, in order to safeguard 
and preserve this important plant biotechnological 
approachs would be very useful (Sivakumar and 
Krishnamurthy, 2002). The conventional method of 
propagation has many disadvantages as  50% of the 
yield has to be set aside for raising the next crop, 
transmittance of soil-borne diseases from one crop to 
the next, and from one location to another and during 
the 2-3 month storage period between harvest and 
the raising of next crop (Mrudul et al., 2001). Kala et 
al. (2004) studied  the prioritization of medicinal plants 
on the basis of available knowledge, existing 
practices and use value status in Uttaranchal, India in 
order to understand the pattern of indigenous uses of 
medicinal plants available in the Uttaranchal state, 
India and documented 300 species including G. 
superba. Hassan and Roy (2005) reported 92% of the 
cultures of apical and axillary buds of young sprout 
from naturally grown G. superba plants regenerate 
four shoots per culture in MS basal medium fortified 
with 1.5 mg/L BA + 0.5 mg/L NAA.  Custers and 
Bergervoet (1994) reported micropropagation of G. 
superba by shoot cuttings and explants from node, 
internode, leaves, flowers, pedicels and tubers. 
G. rothschidiana  (duphur) vs. G. rothschidiana (new 
accession) and G. rothschidiana vs. G. superba were 
cultured on MS basal medium with 3% w/v sucrose, 
0-10 mg/L Benzyl Adenine (BA) and 0.1 mg lndol 
Acetic Acid (IAA) and maintained at 24 days under 16 
hours photoperiod. Addition of low level of Benzyl 
Adenine (BA) (1 mg/L) improved plant growth, 
whereas the high level of BA (10 mg/L) caused 
proliferation of multiple shoots, from rhizome 
meristem, by applying alternatively high and low BA 
level, a method of continued propagation was 
achieved which resulted in a 4-7 fold multiplication of 
qualitatively good plantlets every 18 week. The 
resulting shoots were incubated on MS medium, with 
3% sucrose and 0-1 mg/L IAA or NAA. 
Transplantation into soil was only possible after the 
plants had formed. 
Samarjeeva et al. (1993) studied clonal 
propagation of G. superba from apical bud and node 
segment of shoot tip, cultured on solidified agar (0.8% 
w/v) Gamborg’s B5 medium containing BA, IAA, 
Kinetin, NAA, IBA or 2,4-D. The cultures were 
maintained under fluorescent light at 25-27ºC. 
Primary cultures were initiated in solid B5
  medium 
containing 0.5 to 1 mg/L BA and 0.01-0.5 mg/L IAA, 
IBA, NAA when shoot tip of primary cultures were 
transferred to shoot multiplication media, shoot 
proliferation occurred via adventitious bud formation 
within 4-8 weeks.  
Somani et al. (1989) reported in vitro propagation 
and corm formation in G. superba. The fresh sprouts 
were excised from corms of G. superba and dissected 
propagules with shoot and root primordia were placed 
on MS basal medium (Murashige and Skoog, 1962) 
containing 3% sucrose and 0.6% agar. Explant 
germinated on the MS medium producing shoot and 
root, which formed new corm within one month. For 
shoot and cormlet regeneration, 1-4 mg/L kinetin was 
added to the medium. Cultures were maintained at 
25ºC in white fluorescent light (2500 lux) with an 8-
h/day photoperiod. Sivakumar and Krishnamurthy 
(2002) reported in vitro organogenetic responses of 
G. superba. They used MS medium supplemented 
with ADS and BA, 98%.  The  callus induction 
occurred in non-dormant corm bud explants. The 
maximum number of multiple shoot (57%) was 
observed in corm-derived calluses.  
Gupta (1990) compared  the production of different 
colchicinic substances from G. superba and C. 
autumnale.  He  reported extensive range  of these 
colchicinic compounds like colchicines (0.9%), 
dimethyl-3-colchicine (0.19%), colchicoside (0.82%) 
and their formyl derivatives from G. superba. While 
these values were found to be less in case of C. 
autumnale which were reported as 0.62%, 0.9%, and 
0.39% respectively. Sivakumar and Krishnamurthy 
(2002, 2004) studied induction of embryoids from leaf 
tissue of G. superba. The nodular calli were observed 
on S.H. medium supplemented with 2,4-D and 1 
isopentyldene. Gupta et al. (1999) found 
hepatoprotective activity of G. superba.  Jha et al. 
(2005) reported production of forskolin, withanolides, 
colchicine and tylophorine from plant source by using 
biotechnological approach.  
CONCLUSION 
 Gloriosa  superba is a commercially imperative 
medicinal plant which has diverse medicinal 
applications and eventually due to over-exploitation 
this plant is facing local extinction. It has been 
affirmed as endangered plant by IUCN and hence 
there is a pressing need to conserve the plant by in 
situ and ex situ multiplication  in general and 
micropropagation in particular so as to meet the ever-
increasing demand from the industries. Furthermore, 
responsiveness should be generated among the 
common people concerning the importance of G. 
superba and its overexploitation by the people. 
Peoples participation in conservation of rare and 
endangered medicinal plants like G. superba will also 
be  very useful. 
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